Clinical outcomes of targeted therapies in elderly patients aged ≥ 80 years with metastatic colorectal cancer

Table 3 Salvage chemotherapy

	Group with TA (n: 15)	Group without TA (n: 15)
2nd line chemotherapy, %
Yes	4 (26.7)	8 (53.3)
No	11 (73.3)1	7 (46.7)
2nd line chemotherapy agents, %
FOLFOX	3 (75.0)	0
FOLFIRI	0	6 (75.0)
Capecitabine	1 (25.0)	2 (25.0)
No of chemotherapy line, %
1st line	11* (73.3)	7 (46.7)
2nd line	2 (13.3)	5 (31.3)
3rd line	2 (13.3)	3 (20.0)

¹Two patients with targeted agent had chemotherapy holiday after first-line treatment. FOLFOX: Fluorouracil, leucovorin and oxaliplatin; FOLFIRI: Fluorouracil, leucovorin and irinotecan; TA: Targeted agent.